Susquehanna International Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
|
|||||
|
2025
Q1 | $83K | Buy |
|
|||||
|
2024
Q4 | $71.3K | Sell |
|
|||||
|
2024
Q3 | $141K | Sell |
|
|||||
|
2024
Q2 | $219K | Buy |
|
|||||
|
2024
Q1 | $428K | Sell |
|
|||||
|
2023
Q4 | $354K | Sell |
|
|||||
|
2023
Q3 | $230K | Sell |
|
|||||
|
2023
Q2 | $962K | Buy |
|
|||||
|
2023
Q1 | $1.13M | Buy |
|
|||||
|
2022
Q4 | $234K | Sell |
|
|||||
|
2022
Q3 | $692K | Buy |
|
|||||
|
2022
Q2 | $88K | Sell |
|
|||||
|
2022
Q1 | $693K | Buy |
|
|||||
|
2021
Q4 | $759K | Buy |
|
|||||
|
2021
Q3 | $884K | Sell |
|
|||||
|
2021
Q2 | $1.5M | Sell |
|
|||||
|
2021
Q1 | $2.13M | Buy |
|
|||||
|
2020
Q4 | $350K | Sell |
|
|||||
|
2020
Q3 | $1.29M | Buy |
|
|||||
|
2020
Q2 | $591K | Buy |
|
|||||
|
2020
Q1 | $105K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $26K | Sell |
|
|||||
|
2019
Q2 | $154K | Buy |
|